Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00128102 · BASELINE

Baseline characteristics

Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) · Source last updated 2020-10-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      329
    2. group Id
      BG001
      value
      332
    3. group Id
      BG002
      value
      661
    units
    Participants
groups
  1. description
    Vorinostat three 100 mg capsules twice daily for 3 consecutive days of treatment followed by 4 days of rest repeated weekly, in 21-day cycles. Treatment continued until disease progression or unacceptable toxicity.
    id
    BG000
    title
    Vorinostat
  2. description
    Placebo capsules twice daily for 3 consecutive days of treatment followed by 4 days of rest repeated weekly, in 21-day cycles. Treatment continued until disease progression or unacceptable toxicity.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.5
          value
          64.2
        2. group Id
          BG001
          spread
          9.3
          value
          64.4
        3. group Id
          BG002
          spread
          9.4
          value
          64.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          46
        2. group Id
          BG001
          value
          62
        3. group Id
          BG002
          value
          108
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          283
        2. group Id
          BG001
          value
          270
        3. group Id
          BG002
          value
          553
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      329
    2. group Id
      BG001
      value
      332
    3. group Id
      BG002
      value
      661
    units
    Participants
groups
  1. description
    Vorinostat three 100 mg capsules twice daily for 3 consecutive days of treatment followed by 4 days of rest repeated weekly, in 21-day cycles. Treatment continued until disease progression or unacceptable toxicity.
    id
    BG000
    title
    Vorinostat
  2. description
    Placebo capsules twice daily for 3 consecutive days of treatment followed by 4 days of rest repeated weekly, in 21-day cycles. Treatment continued until disease progression or unacceptable toxicity.
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.5
          value
          64.2
        2. group Id
          BG001
          spread
          9.3
          value
          64.4
        3. group Id
          BG002
          spread
          9.4
          value
          64.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          46
        2. group Id
          BG001
          value
          62
        3. group Id
          BG002
          value
          108
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          283
        2. group Id
          BG001
          value
          270
        3. group Id
          BG002
          value
          553
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice